{
  "id": 10610111,
  "title": "Why rare-disease drugs could become India’s next pharma frontier",
  "url": "https://urgent.news/2026/09/29/why-rare-disease-drugs-could-become-indias-next-pharma-frontier-10610111",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-29T04:03:05.000Z",
  "source": {
    "name": "The Hindu",
    "slug": "the-hindu",
    "url": "https://www.thehindu.com/sci-tech/science/rare-disease-drugs-could-become-indias-next-pharma-frontier/article71518560.ece"
  },
  "original_language": "en",
  "account": null,
  "summary": "Since India has already shown the world how to make drugs affordable, the next challenge is to show the world how to make rare-disease drugs accessible; with a streamlined regulatory pathway, appropriate financial incentives, and government procurement, India could build a globally competitive rare-disease pharmaceutical sector",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Hindu - Sci-Tech",
        "title": "Why rare-disease drugs could become India’s next pharma frontier",
        "url": "https://urgent.news/2026/09/29/why-rare-disease-drugs-could-become-indias-next-pharma-frontier",
        "published": "2026-09-29T04:03:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}